Sponsor:
Oana Danciu
Code:
NCT05467891
Conditions
Locoregional Recurrence
Hormone Receptor-positive Breast Cancer
HER2-negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ribociclib
Fulvestrant
Anastrozole
Letrozole
Exemestane
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-30. This information was provided to ClinicalTrials.gov by Oana Danciu on 2025-04-08.